Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News OPKO Health Inc OPK

Healthcare Diagnostics & Research
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing,... see more

Recent & Breaking News (NDAQ:OPK)

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 6, 2026

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire November 19, 2025

NextPlat Reports Third Quarter 2025 Results

PR Newswire November 13, 2025

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

GlobeNewswire October 29, 2025

OPKO Health's ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications

GlobeNewswire October 29, 2025

OPKO Health's ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers

GlobeNewswire October 28, 2025

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

GlobeNewswire October 22, 2025

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

PR Newswire September 15, 2025

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

GlobeNewswire July 31, 2025

OPKO Health to Report Second Quarter 2025 Financial Results on July 31

GlobeNewswire July 24, 2025

OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress

GlobeNewswire July 8, 2025

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

GlobeNewswire June 25, 2025

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting

GlobeNewswire June 25, 2025

OPKO Health's ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

GlobeNewswire June 9, 2025

OPKO Health to Participate in Two Upcoming Investor Conferences

GlobeNewswire May 15, 2025

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results

GlobeNewswire April 30, 2025

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025

GlobeNewswire April 17, 2025

NextPlat Provides Statement on U.S. Tariff Impact on its E-Commerce Development Program

PR Newswire April 11, 2025

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

GlobeNewswire April 4, 2025

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

GlobeNewswire March 17, 2025

Podcasts